AVEXIS, INC. AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • February 28th, 2018 • AveXis, Inc. • Biological products, (no disgnostic substances) • Illinois
Contract Type FiledFebruary 28th, 2018 Company Industry JurisdictionThis Amended and Restated Employment Agreement (the “Agreement”) made between Sean Nolan (the “Executive”) and AveXis, Inc. (the “Company”), amends and restates in its entirety the Employment Agreement between the Company and Executive that was effective as of June 8, 2015. This Agreement is effective as of February 26, 2018 (the “Effective Date”).
FIRST AMENDMENT TO LICENSE AGREEMENTLicense Agreement • February 28th, 2018 • AveXis, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledFebruary 28th, 2018 Company IndustryThis First Amendment to License Agreement (the “First Amendment”) is made as of January 8, 2018 (the “First Amendment Effective Date”) by and between REGENXBIO Inc. (formerly known as ReGenX Biosciences, LLC), a corporation organized under the laws of the State of Delaware, with offices at 9600 Blackwell Road, Suite 210, Rockville, MD 20850 (“Licensor”), and AveXis, Inc., a corporation organized under the laws of the State of Delaware, with offices at 2275 Half Day Road, Suite 200, Bannockburn, IL 60015 (“Licensee”). Licensor and Licensee are hereinafter referred to individually as a “Party” and collectively as the “Parties.”